Latin American scientific production on nanotechnology-based products to fight COVID-19: a scoping review: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02002 | Published on: 27/02/2023

Detalhes bibliográficos
Autor(a) principal: Mota, Daniel Marques
Data de Publicação: 2023
Outros Autores: Gonçalves Ferreira, Paulo José, Teixeira Primo, Fabian
Tipo de documento: Artigo
Idioma: por
eng
Título da fonte: Vigilância Sanitária em Debate
Texto Completo: https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/2002
Resumo: Introduction: Scientific production has experienced an unprecedented increase with the COVID-19 pandemic in a short period of time. Objective: To identify and characterize the Latin American scientific production on anotechnology-based products with potential applications in the areas of diagnosis, vaccine, pharmacological treatment, theranostics and non-pharmacological intervention to fight COVID-19. Method: A scoping review was conducted based on the framework of Arksey and O’Malley and sought to incorporate recommendations from the Joanna Briggs Institute Reviewer’s Manual and Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR). The bibliographic search took place in PubMed, Science Direct, LILACS and SciELO. Studies that reported nanotechnology-based products with potential applications in the areas of interest referenced previously were included. A simple quantitative analysis was conducted to provide numerical summaries of characteristics of interest from the studies added to the review. Results: 26 (3.4%) articles published in 14  international and regional journals were included. Authors from five countries (Brazil, Chile, Costa Rica, Ecuador, and Mexico) were responsible for the total number of articles that made up the review. The production of 6 (23.1%) articles included international collaboration, involving institutions from 10 countries. The median time from submission to publication of articles was 126 days (interquartile range: 58–200). Most of the Latin American scientific production consisted of narrative reviews (n = 19; 73.1%). The five areas defined as of interest for this study were addressed by one of the scientific articles, especially the products intended for pharmacological treatment of COVID-19 (n = 14; 53.8%). Conclusions: This is the first scoping review to provide a map of Latin American scientific production on nanotechnology-based products with potential applications in areas of interest to fight COVID-19. There are deficiencies related to the publication of basic research, representativeness of Latin American countries in the region, studies with greater strength of evidence and to international collaboration to produce scientific articles that merit to be reduced.
id FIOCRUZ-9_2efa46c1c61259c131955f0c52498385
oai_identifier_str oai:ojs.visaemdebate.incqs.fiocruz.br:article/2002
network_acronym_str FIOCRUZ-9
network_name_str Vigilância Sanitária em Debate
repository_id_str
spelling Latin American scientific production on nanotechnology-based products to fight COVID-19: a scoping review: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02002 | Published on: 27/02/2023Produção científica latino-americana sobre produtos à base de nanotecnologia para o enfrentamento da COVID-19: uma revisão de escopo: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02002 | Publicado em: 27/02/2023 COVID-19Infecções por CoronavirusNanomedicinaNanotecnologiaRevisão de EscopoNanotecnologiaCOVID-19Coronavirus InfectionsNanomedicineNanotechnologyScoping ReviewIntroduction: Scientific production has experienced an unprecedented increase with the COVID-19 pandemic in a short period of time. Objective: To identify and characterize the Latin American scientific production on anotechnology-based products with potential applications in the areas of diagnosis, vaccine, pharmacological treatment, theranostics and non-pharmacological intervention to fight COVID-19. Method: A scoping review was conducted based on the framework of Arksey and O’Malley and sought to incorporate recommendations from the Joanna Briggs Institute Reviewer’s Manual and Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR). The bibliographic search took place in PubMed, Science Direct, LILACS and SciELO. Studies that reported nanotechnology-based products with potential applications in the areas of interest referenced previously were included. A simple quantitative analysis was conducted to provide numerical summaries of characteristics of interest from the studies added to the review. Results: 26 (3.4%) articles published in 14  international and regional journals were included. Authors from five countries (Brazil, Chile, Costa Rica, Ecuador, and Mexico) were responsible for the total number of articles that made up the review. The production of 6 (23.1%) articles included international collaboration, involving institutions from 10 countries. The median time from submission to publication of articles was 126 days (interquartile range: 58–200). Most of the Latin American scientific production consisted of narrative reviews (n = 19; 73.1%). The five areas defined as of interest for this study were addressed by one of the scientific articles, especially the products intended for pharmacological treatment of COVID-19 (n = 14; 53.8%). Conclusions: This is the first scoping review to provide a map of Latin American scientific production on nanotechnology-based products with potential applications in areas of interest to fight COVID-19. There are deficiencies related to the publication of basic research, representativeness of Latin American countries in the region, studies with greater strength of evidence and to international collaboration to produce scientific articles that merit to be reduced.Introdução: A produção científica tem experimentado um aumento sem precedentes com a pandemia de COVID-19 em um curto espaço de tempo. Objetivo: Identificar e caracterizar a produção científica latino-americana sobre produtos à base de nanotecnologia com potenciais aplicações nas áreas de diagnóstico, vacina, tratamento farmacológico, teranóstico e intervenção não farmacológica para o enfrentamento da COVID-19. Método: Uma revisão de escopo foi conduzida com base na estrutura de Arksey e O’Malley e buscou incorporar recomendações do Joanna Briggs Institute Reviewer’s Manual e do Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR). A busca bibliográfica ocorreu na PubMed, Science Direct, LILACS e SciELO. Estudos que relataram produtos à base de nanotecnologia com potenciais aplicações nas áreas de interesse referenciadas anteriormente foram incluídos. Uma análise quantitativa simples foi conduzida para fornecer resumos numéricos das características de interesse dos estudos adicionados na revisão. Resultados: Foram incluídos 26 (3,4%) artigos publicados em 14 revistas internacionais e regionais. Autores de cinco países (Brasil, Chile, Costa Rica, Equador e México) foram responsáveis pelos artigos que compuseram a revisão. A colaboração internacional ocorreu para a produção de seis (23,1%) artigos, envolvendoinstituições de dez países. O tempo mediano do envio à publicação dos artigos foi de 126 dias (intervalo interquartil: 58–200). A maior parte da produção científica latinoamericana foi de revisões narrativas (n = 19; 73,1%). As cinco áreas definidas como de interesse deste estudo foram abordadas por algum dos artigos científicos, com destaque para os produtos destinados ao tratamento farmacológico da COVID-19 (n = 14; 53,8%). Conclusões: Esta é a primeira revisão de escopo a fornecer um mapa da produção científica latino-americana sobre produtos à base de nanotecnologia com potenciais aplicações em áreas de interesse para o enfrentamento da COVID-19. Existem deficiências relativas à publicação de pesquisa básica, representatividade de países da América Latina, estudos com maior força de evidência e colaboração internacional para a produção de artigos científicos que merecem ser reduzidas.Instituto Nacional de Controle de Qualidade em Saúde2023-02-27info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion"Peer-reviewed article""Artículo revisado por pares""Artigo avaliado pelos pares"application/pdfapplication/pdfhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/200210.22239/2317-269x.02002Health Surveillance under Debate: Society, Science & Technology ; v. 11 (2023) | Continuous publication; 1-12Vigilancia en Salud en Debate: Sociedad, Ciencia y Tecnología; v. 11 (2023) | Publicación continua; 1-12Vigil Sanit Debate, Rio de Janeiro; v. 11 (2023) | Publicação contínua; 1-122317-269Xreponame:Vigilância Sanitária em Debateinstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZporenghttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/2002/1485https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/2002/1590https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/2002/1526https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/2002/1527https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/2002/1528Copyright (c) 2023 Daniel Marques Mota, Paulo José Gonçalves Ferreira, Fabian Teixeira Primo (Autor)https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessMota, Daniel MarquesGonçalves Ferreira, Paulo JoséTeixeira Primo, Fabian2024-02-21T17:53:10Zoai:ojs.visaemdebate.incqs.fiocruz.br:article/2002Revistahttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebatePUBhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/oaiincqs.visaemdebate@fiocruz.br || gisele.neves@fiocruz.br2317-269X2317-269Xopendoar:2024-02-21T17:53:10Vigilância Sanitária em Debate - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.none.fl_str_mv Latin American scientific production on nanotechnology-based products to fight COVID-19: a scoping review: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02002 | Published on: 27/02/2023
Produção científica latino-americana sobre produtos à base de nanotecnologia para o enfrentamento da COVID-19: uma revisão de escopo: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02002 | Publicado em: 27/02/2023
title Latin American scientific production on nanotechnology-based products to fight COVID-19: a scoping review: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02002 | Published on: 27/02/2023
spellingShingle Latin American scientific production on nanotechnology-based products to fight COVID-19: a scoping review: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02002 | Published on: 27/02/2023
Mota, Daniel Marques
COVID-19
Infecções por Coronavirus
Nanomedicina
Nanotecnologia
Revisão de Escopo
Nanotecnologia
COVID-19
Coronavirus Infections
Nanomedicine
Nanotechnology
Scoping Review
title_short Latin American scientific production on nanotechnology-based products to fight COVID-19: a scoping review: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02002 | Published on: 27/02/2023
title_full Latin American scientific production on nanotechnology-based products to fight COVID-19: a scoping review: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02002 | Published on: 27/02/2023
title_fullStr Latin American scientific production on nanotechnology-based products to fight COVID-19: a scoping review: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02002 | Published on: 27/02/2023
title_full_unstemmed Latin American scientific production on nanotechnology-based products to fight COVID-19: a scoping review: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02002 | Published on: 27/02/2023
title_sort Latin American scientific production on nanotechnology-based products to fight COVID-19: a scoping review: Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02002 | Published on: 27/02/2023
author Mota, Daniel Marques
author_facet Mota, Daniel Marques
Gonçalves Ferreira, Paulo José
Teixeira Primo, Fabian
author_role author
author2 Gonçalves Ferreira, Paulo José
Teixeira Primo, Fabian
author2_role author
author
dc.contributor.author.fl_str_mv Mota, Daniel Marques
Gonçalves Ferreira, Paulo José
Teixeira Primo, Fabian
dc.subject.por.fl_str_mv COVID-19
Infecções por Coronavirus
Nanomedicina
Nanotecnologia
Revisão de Escopo
Nanotecnologia
COVID-19
Coronavirus Infections
Nanomedicine
Nanotechnology
Scoping Review
topic COVID-19
Infecções por Coronavirus
Nanomedicina
Nanotecnologia
Revisão de Escopo
Nanotecnologia
COVID-19
Coronavirus Infections
Nanomedicine
Nanotechnology
Scoping Review
description Introduction: Scientific production has experienced an unprecedented increase with the COVID-19 pandemic in a short period of time. Objective: To identify and characterize the Latin American scientific production on anotechnology-based products with potential applications in the areas of diagnosis, vaccine, pharmacological treatment, theranostics and non-pharmacological intervention to fight COVID-19. Method: A scoping review was conducted based on the framework of Arksey and O’Malley and sought to incorporate recommendations from the Joanna Briggs Institute Reviewer’s Manual and Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR). The bibliographic search took place in PubMed, Science Direct, LILACS and SciELO. Studies that reported nanotechnology-based products with potential applications in the areas of interest referenced previously were included. A simple quantitative analysis was conducted to provide numerical summaries of characteristics of interest from the studies added to the review. Results: 26 (3.4%) articles published in 14  international and regional journals were included. Authors from five countries (Brazil, Chile, Costa Rica, Ecuador, and Mexico) were responsible for the total number of articles that made up the review. The production of 6 (23.1%) articles included international collaboration, involving institutions from 10 countries. The median time from submission to publication of articles was 126 days (interquartile range: 58–200). Most of the Latin American scientific production consisted of narrative reviews (n = 19; 73.1%). The five areas defined as of interest for this study were addressed by one of the scientific articles, especially the products intended for pharmacological treatment of COVID-19 (n = 14; 53.8%). Conclusions: This is the first scoping review to provide a map of Latin American scientific production on nanotechnology-based products with potential applications in areas of interest to fight COVID-19. There are deficiencies related to the publication of basic research, representativeness of Latin American countries in the region, studies with greater strength of evidence and to international collaboration to produce scientific articles that merit to be reduced.
publishDate 2023
dc.date.none.fl_str_mv 2023-02-27
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
"Peer-reviewed article"
"Artículo revisado por pares"
"Artigo avaliado pelos pares"
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/2002
10.22239/2317-269x.02002
url https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/2002
identifier_str_mv 10.22239/2317-269x.02002
dc.language.iso.fl_str_mv por
eng
language por
eng
dc.relation.none.fl_str_mv https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/2002/1485
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/2002/1590
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/2002/1526
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/2002/1527
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/2002/1528
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Instituto Nacional de Controle de Qualidade em Saúde
publisher.none.fl_str_mv Instituto Nacional de Controle de Qualidade em Saúde
dc.source.none.fl_str_mv Health Surveillance under Debate: Society, Science & Technology ; v. 11 (2023) | Continuous publication; 1-12
Vigilancia en Salud en Debate: Sociedad, Ciencia y Tecnología; v. 11 (2023) | Publicación continua; 1-12
Vigil Sanit Debate, Rio de Janeiro; v. 11 (2023) | Publicação contínua; 1-12
2317-269X
reponame:Vigilância Sanitária em Debate
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Vigilância Sanitária em Debate
collection Vigilância Sanitária em Debate
repository.name.fl_str_mv Vigilância Sanitária em Debate - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv incqs.visaemdebate@fiocruz.br || gisele.neves@fiocruz.br
_version_ 1797042046628790272